Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment-Reference-Cited by-同舟云学术

Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment

Published:2020-04-01 Issue:10 Volume:38 Page:1115-1116
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Adams Hugo J.A.¹,Kwee Thomas C.¹

Affiliation:

1. Hugo J.A. Adams, MD, PhD, Department of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, Department of Radiology, Nuclear Medicine, and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.02780

Reference5 articles.

1. Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group

2. A negative 18F-FDG-PET scan can never exclude residual disease

3. Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy

4. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

5. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to H.J.A. Adams et al;Journal of Clinical Oncology;2020-04-01